Abstract The global incidence of steatotic liver disease (SLD), driven by metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-associated liver disease (ALD), and the synergistic metabolic dysfunction and alcohol-associated liver disease (MetALD), is fueling a rapid rise in hepatocellular carcinoma (HCC)
Summary: A recent study suggests that a GLP-1 drug, liraglutide, may protect the brains of people with mild Alzheimers disease, slowing cognitive decline by 18% over one year
But there is a need for families to reduce their out-of-pocket expenses so that they can hopefully catch up
has a long record of success in the courtroom and is fully prepared to litigate your claim before a judge and jury if necessary
They can rule out other causes and refer you to a registered dietitian or physical therapist if appropriate
While natural GLP-1 rarely causes problems, pharmaceutical GLP-1 agonists commonly cause gastrointestinal side effects including nausea, vomiting, diarrhea, and constipation, particularly during dose escalation